Nykode Therapeutics posts new press release on VB10.NEO data update

Reuters2026/07/22 12:05

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nykode published a July 22, 2026 update on VB10.NEO, its individualized neoantigen therapy, highlighting new preclinical and clinical immunogenicity data.
Manufacturing turnaround-time cut to under six weeks from biopsy to release, with a stated path to further reductions via in-house consolidation.
Post-hoc analysis linked stronger de novo immune responses with improved overall survival in patients with low baseline immunogenicity.
Company flagged VB10.NEO as partnership-ready; poster link: https://nykode.com/research-and-development/scientific-papers-and-presentations/.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nykode Therapeutics AS published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nykode Therapeutics posts new press release on VB10.NEO data update

You may also like

Crypto prices